article thumbnail

Cooley’s 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024

JD Supra: Mergers

In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024.

M&A 169
article thumbnail

DOJ Announces New Safe Harbor Policy for Voluntary Self-Disclosure in M&A

JD Supra: Mergers

To that end, the DOJ recently announced its decision to decline to prosecute Lifecore Biomedical, a pharmaceutical and medical device manufacturer, despite evidence that employees of Lifecore’s former US subsidiary bribed Mexican government officials in violation of the Foreign Corrupt Practices Act.

M&A 169
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Doing Life Sciences Deals in 2024

JD Supra: Mergers

I moderated a panel, “Structuring Your Life Sciences Transaction: Licensing vs. M&A vs. Asset Sale,” with business development leaders from GSK, Johnson & Johnson, Locust Walk, and Astria Therapeutics.

article thumbnail

Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.

Global Newswire by Notified: M&A

Nika Pharmaceuticals, Inc. OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.

article thumbnail

M&A Partner Valarie Ney Joins Hunton Andrews Kurth in Washington

Global Newswire by Notified: M&A

12, 2023 (GLOBE NEWSWIRE) -- Valarie Ney , an experienced corporate and M&A attorney, has joined Hunton Andrews Kurth LLP as a partner in Washington, D.C. Ney represents clients from a broad array of industries, including the government contracting, pharmaceutical, healthcare, energy, technology and manufacturing sectors.

M&A 52
article thumbnail

IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma

Global Newswire by Notified: M&A

a European distributor in the pharmaceutical and nutraceutical industry. ROTTERDAM, The Netherlands 24 April 2024 – IMCD N.V. IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Spain has signed an agreement to acquire 100% of the shares in Cobapharma, S.L.U,

article thumbnail

Biogen to Acquire Reata Pharmaceuticals

Global Newswire by Notified: M&A

Nasdaq: BIIB) and Reata Pharmaceuticals, Inc. CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. Nasdaq: RETA) today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3